PMC:7172841 / 33967-34052
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T231 | 9-19 | Body_part | denotes | lymphocyte | http://purl.org/sig/ont/fma/fma62863 |
T232 | 20-25 | Body_part | denotes | blood | http://purl.org/sig/ont/fma/fma9670 |
LitCovid-PD-UBERON
Id | Subject | Object | Predicate | Lexical cue | uberon_id |
---|---|---|---|---|---|
T35 | 20-25 | Body_part | denotes | blood | http://purl.obolibrary.org/obo/UBERON_0000178 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T310 | 20-25 | http://purl.obolibrary.org/obo/UBERON_0000178 | denotes | blood |
T311 | 20-25 | http://www.ebi.ac.uk/efo/EFO_0000296 | denotes | blood |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T266 | 0-85 | Sentence | denotes | Absolute lymphocyte blood counts were compared before and after Tocilizumab infusion. |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T946 | 9-19 | CL:0000542 | denotes | lymphocyte |
T947 | 20-25 | UBERON:0000178 | denotes | blood |
T948 | 64-75 | DG_35 | denotes | Tocilizumab |
T55151 | 9-19 | CL:0000542 | denotes | lymphocyte |
T59630 | 20-25 | UBERON:0000178 | denotes | blood |
T53589 | 64-75 | DG_35 | denotes | Tocilizumab |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
1200 | 64-75 | Chemical | denotes | Tocilizumab | MESH:C502936 |